At a glance
ClinicalIndex Comparison RecordN/ACompleted· 28 enrolled
Drug / intervention
Retrospective chart reviewdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Retrospective Analysis of the Use of Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair
In Brief
An observational study evaluating Retrospective chart review for Ventral Hernia. Completed, enrolled 28 participants across 1 site.
Detailed Summary
The purpose of this study is to collect additional safety data and demonstrate the performance of Integra Gentrix® Surgical Matrix for reinforcement of ventral hernia repairs.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVentral Hernia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedNov 2022
Enrollment StartNov 2022
Primary CompletionDec 2022
TodayJul 2026
First PostedNov 9, 2022
Enrollment StartNov 22, 2022
Primary CompletionDec 28, 2022
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 3.6 years ago
Interventions
Retrospective chart reviewdevice
The retrospective chart review will include the full consecutive series of patients between 22 years and 80 years old who underwent abdominal wall reconstruction for achart hernia with Integra Gentrix® Surgical Matrix during the time period between November 1, 2017, and present (90 days prior to the start of data collection).